Form 8-K SOLAZYME INC For: Jul 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Solazyme (SZYM) Posts Q2 Loss of $0.43/Share
July 30, 2014 4:14 PM EDTSolazyme (NASDAQ: SZYM) reported Q2 EPS of ($0.43), $0.07 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $17.13 million.
For earnings history and earnings-related data on Solazyme (SZYM) click here.
... More